Economic and Clinical Impact of Stroke and Warfarin Use for Patients with Non-valvular Atrial Fibrillation
**Background:** Atrial fibrillation (AF) is a common clinical problem and potent risk factor for stroke. However, real-world effectiveness and outcomes for AF patients are not well described. **Objective:** To compare the economic and clinical impact of stroke and warfarin use on patients with nonv...
Saved in:
Main Authors: | Li Wang, Elyse Fritschel, Onur Baser |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2013-11-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9852 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors Associated with Cardioembolic Stroke in Patients with non Valvular Atrial Fibrillation
by: Daniel Guerra García, et al.
Published: (2018-02-01) -
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
by: Carlos Rubio-Terrés, et al.
Published: (2016-02-01) -
Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.
by: Navkaranbir S Bajaj, et al.
Published: (2016-01-01) -
The methods of treatment of atrial fibrillation in patients with valvular heart disease
by: O.M. Grytsay, et al.
Published: (2019-03-01) -
The Study of Cost-Effectiveness of Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Who Developed Ischemic Stroke
by: Neda Jaberi, et al.
Published: (2021-01-01)